MS023 二盐酸盐
中文名称 | MS023 二盐酸盐 |
---|---|
中文同义词 | MS-023 HCL(新增分子);化合物 MS023 DIHYDROCHLORIDE |
英文名称 | MS023 dihydrochloride |
英文同义词 | MS023 dihydrochloride;N1-[4-(4-Isopropoxy-phenyl)-1H-pyrrol-3-ylmethyl]-N1-methyl-ethane-1,2-diamine dihydrochloride;MS-023 2HCl |
CAS号 | 1992047-64-9 |
分子式 | C17H26ClN3O |
分子量 | 323.87 |
EINECS号 | |
相关类别 | |
Mol文件 | 1992047-64-9.mol |
结构式 |
MS023 二盐酸盐 性质
储存条件 | Store at -20°C |
---|---|
溶解度 | 二甲基亚砜:≥ 150 mg/mL(416.30 mM) |
IC50: 30 nM (PRMT1), 119 nM (PRMT3), 83 nM (PRMT4), 4 nM (PRMT6), 5 nM (PRMT8)
MS023 (1-1000 nM; 48 hours) inhibits PRMT1 methyltransferase activity in MCF7 cells.
MS023(1-1000 nM; 20 hours) inhibits PRMT6 methyltransferase activity in HEK293 cells.
Western Blot Analysis
Cell Line: | MCF7 and HEK293 cells |
Concentration: | 1.4, 4, 12, 37, 111, 333, and 1000 nM |
Incubation Time: | 48 hours for MCF7 cells; 20 hours for HEK293 cells |
Result: |
Treatment potently and concentration-dependently reduced cellular levels of H4R3me2a (IC
50
=9±0.2 nM).
Treatment concentration-dependently reduced the H3R2me2a mark (IC 50 =56±7 nM). |
Administration of MS023 (160 mg/kg, i.p) in combination with PKC412 (100 mg/kg, i.g.) blocks MLL-r acute lymphoblastic leukemia (ALL) propagation by inhibiting maintenance of functional MLL-r ALL-initiating cells.
Animal Model: | NOD-scid IL2Rgnull (NSG) mice bearing primary MLL-r ALL cells |
Dosage: | 160 mg/kg |
Administration: | Intraperitoneal injection; PKC412 (100 mg/kg, i.g.), MS023 (160 mg/kg, i.p), or a combination for 4 weeks |
Result: | Combinatorial treatment extended survival of leukemic mice relative to single treatments. |
安全信息
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024/04/30 | HY-19615B | MS023 DIHYDROCHLORIDE MS023 dihydrochloride | 1992047-64-9 | 2mg | 760元 |
2024/04/30 | HY-19615B | MS023 DIHYDROCHLORIDE MS023 dihydrochloride | 1992047-64-9 | 10mM * 1mLin DMSO | 793元 |